|Bid||162.35 x 800|
|Ask||162.42 x 800|
|Day's range||160.82 - 163.70|
|52-week range||120.24 - 354.82|
|Beta (5Y monthly)||1.02|
|PE ratio (TTM)||8.27|
|Earnings date||15 Nov 2021 - 19 Nov 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||253.22|
Anastasia Amoroso, iCapital Network Chief Investment Strategist, joins Yahoo Finance Live to share why she sees a potential pullback from the stock market in September, what’s next for the crypto market and chats regulatory risks in China.
One of the most exciting stocks investors can scoop up in the healthcare space at a significant discount to where it was trading in February is telemedicine kingpin Teladoc Health (NYSE: TDOC). Teladoc's 54% retracement looks to be tied to two factors. First, the acquisition of Livongo Health has increased the company's 2021 costs (mostly one-time expenses) and widened its net loss projections well beyond what Wall Street was expecting.
LOS ANGELES, September 08, 2021--INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims on Behalf of Investors in Baidu, Inc.